Zurich Cantonal Bank’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 2584 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2643 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2644 |
|
|
2024
Q3 | – | Sell |
-11,872
| Closed | -$179K | – | 2659 |
|
|
2024
Q2 | $265K | Buy |
11,872
+96
| +0.8% | +$2.97K | ﹤0.01% | 1906 |
|
|
2024
Q1 | $692K | Buy |
11,776
+96
| +0.8% | +$4.14K | ﹤0.01% | 1272 |
|
|
2023
Q4 | $259K | Sell |
11,680
-64
| -0.5% | -$965 | ﹤0.01% | 1931 |
|
|
2023
Q3 | $253K | Buy |
11,744
+8,035
| +217% | +$316K | ﹤0.01% | 1824 |
|
|
2023
Q2 | $250K | Buy |
3,709
+1,535
| +71% | +$635K | ﹤0.01% | 1770 |
|
|
2023
Q1 | $1.01M | Sell |
2,174
-1,528
| -41% | -$808K | ﹤0.01% | 890 |
|
|
2022
Q4 | $1.48M | Buy |
3,702
+359
| +11% | +$138K | 0.01% | 746 |
|
|
2022
Q3 | $1.09M | Buy |
3,343
+701
| +27% | +$226K | 0.01% | 822 |
|
|
2022
Q2 | $698K | Sell |
2,642
-8
| -0.3% | -$2.04K | ﹤0.01% | 1018 |
|
|
2022
Q1 | $796K | Sell |
2,650
-117
| -4% | -$40.8K | ﹤0.01% | 1046 |
|
|
2021
Q4 | $975K | Buy |
2,767
+421
| +18% | +$131K | ﹤0.01% | 1020 |
|
|
2021
Q3 | $599K | Buy |
2,346
+823
| +54% | +$292K | ﹤0.01% | 1184 |
|
|
2021
Q2 | $1.01M | Sell |
1,523
-3
| -0.2% | -$1.73K | 0.01% | 893 |
|
|
2021
Q1 | $1.32M | Buy |
1,526
+144
| +10% | +$153K | 0.01% | 808 |
|
|
2020
Q4 | $1.28M | Buy |
1,382
+344
| +33% | +$362K | 0.01% | 860 |
|
|
2020
Q3 | $1.07M | Buy |
1,038
+665
| +178% | +$716K | 0.01% | 834 |
|
|
2020
Q2 | $378K | Buy |
373
+121
| +48% | +$112K | ﹤0.01% | 1149 |
|
|
2020
Q1 | $219K | Buy |
252
+42
| +20% | +$41.8K | ﹤0.01% | 1182 |
|
|
2019
Q4 | $225K | Buy |
210
+21
| +11% | +$21.4K | ﹤0.01% | 1274 |
|
|
2019
Q3 | $175K | Buy |
189
+15
| +9% | +$16.5K | ﹤0.01% | 1307 |
|
|
2019
Q2 | $196K | Hold |
174
| – | – | ﹤0.01% | 1235 |
|
|
2019
Q1 | $236K | Sell |
174
-36
| -17% | -$48.8K | ﹤0.01% | 1114 |
|
|
2018
Q4 | $243K | Buy |
210
+24
| +13% | +$27K | ﹤0.01% | 1106 |
|
|
2018
Q3 | $282K | Buy |
186
+6
| +3% | +$9.24K | ﹤0.01% | 1121 |
|
|
2018
Q2 | $282K | Buy |
180
+25
| +16% | +$32.6K | ﹤0.01% | 1073 |
|
|
2018
Q1 | $179K | Hold |
155
| – | – | ﹤0.01% | 1259 |
|
|
2017
Q4 | $184K | Buy |
155
+46
| +42% | +$57.7K | ﹤0.01% | 1230 |
|
|
2017
Q3 | $147K | Buy |
109
+31
| +40% | +$32.7K | ﹤0.01% | 1158 |
|
|
2017
Q2 | $63K | Buy |
78
+15
| +24% | +$10.4K | ﹤0.01% | 1624 |
|
|
2017
Q1 | $39K | Hold |
63
| – | – | ﹤0.01% | 1918 |
|
|
2016
Q4 | $34K | Buy |
63
+9
| +17% | +$4.49K | ﹤0.01% | 1971 |
|
|
2016
Q3 | $28K | Hold |
54
| – | – | ﹤0.01% | 2056 |
|
|
2016
Q2 | $22K | Hold |
54
| – | – | ﹤0.01% | 2025 |
|
|
2016
Q1 | $29K | Hold |
54
| – | – | ﹤0.01% | 1754 |
|
|
2015
Q4 | $41K | Buy |
54
+30
| +125% | +$19.9K | ﹤0.01% | 1547 |
|
|
2015
Q3 | $13K | Buy |
+24
| New | +$14.5K | ﹤0.01% | 1732 |
|
Other funds holding KYNB
AC
CCM
Zurich Cantonal Bank's KYNB Position: Q2 2025 in Review
Zurich Cantonal Bank held its Kyntra Bio (KYNB) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2584.
Zurich Cantonal Bank first reported a position in KYNB in Q3 2015 and has held it in 36 quarters since. The position peaked at $1.48M in Q4 2022. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.
- Zurich Cantonal Bank held 0 shares of Kyntra Bio worth $0 as of Q2 2025.
- Zurich Cantonal Bank left its Kyntra Bio share count unchanged in Q2 2025.
- Kyntra Bio made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2025, its #2584 holding.
- Zurich Cantonal Bank first reported a position in Kyntra Bio in Q3 2015 and has held it in 36 quarters since.
- Zurich Cantonal Bank's Kyntra Bio position peaked at $1.48M in Q4 2022.
- 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.
Based on Zurich Cantonal Bank's 13F filing for Q2 2025, filed 7 Aug 2025.